Mutational signature profiling classifies subtypes of clinically different mismatch repair deficient tumors with a differential immunogenic response potential
Mar Giner-Calabuig, Seila De Leon, Julian Wang, Tara D. Fehlmann, Chinedu I. Ukaegbu, Joanna A. Gibson, Miren Alustiza, María Dolores Picó, Cristina Alenda, Maite Herráiz, Marta Carrillo Palau, Inmaculada Salces, José Reyes, Silvia P. Ortega, Antònia Obrador‐Hevia, , Rosa M. Xicola
This study classifies MMR-deficient tumors into subtypes based on mutational signatures and immunogenic potential, revealing clinical and molecular differences.
bioRxiv · Sep 28, 2021 · PreprintGenomics